MDGL — Madrigal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $10.62bn
- $10.13bn
- $958.40m
Madrigal Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Madrigal Pharmaceuticals Q2 EPS USD -7.1
Madrigal Pharmaceuticals Inc expected to post a loss of $7.53 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gold miners , Cytokinetics, Novavax
U.S. STOCKS ON THE MOVE-Chemours, Hyster-Yale, Guidewire
NASH drug developers fall after Eli Lilly's obesity drug shows liver scarring benefit
Brief: Madrigal Pharmaceuticals Files For Common Stock Offering Of Up To $300 Mln
Brief: Madrigal Pharmaceuticals Files For Mixed Shelf
U.S. STOCKS ON THE MOVE-Henry Schein, Dave, Delek
U.S. STOCKS ON THE MOVE-Vanda Pharmaceuticals, FMC, Duke Energy
Madrigal falls on 'light' details on recently approved NASH drug launch
Madrigal falls on 'light' details on recently approved NASH drug launch
Madrigal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Madrigal Pharmaceuticals Q1 EPS USD -7.38
Madrigal Pharmaceuticals Inc expected to post a loss of $6.28 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AZZ, Vanda Pharma, Matterport
Refile: BUZZ-Madrigal Pharma falls as BofA initiates coverage with 'underperform' rating
Brief: Madrigal Announces US Availability Of Drug For Treatment Of Fatty Liver Disease NASH
U.S. STOCKS ON THE MOVE-US energy sector, Avis, NuScale